Announcements Trials
Browse Landscape

Status

Unknown 1Completed 1

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Observational 2

Sponsor

Conditions

Lymphocele 1Lymphatic Abnormalities 1Lymphangioma 1

Interventions

Cisplatin 3202Cyclophosphamide 3195Carboplatin 2977Radiotherapy 2790Paclitaxel 2718Gemcitabine 2572pembrolizumab 2385Bevacizumab 2209Docetaxel 2199Fluorouracil 1851Capecitabine 1833Oxaliplatin 1742Dexamethasone 1605Nivolumab 1581Doxorubicin 1501Rituximab 1488Magnetic Resonance Spectroscopy 1387Etoposide 1346Irinotecan 1248Leucovorin 1226Drug Therapy 1205Cytarabine 1130Pemetrexed 1076fludarabine 1063Specimen Handling 1017Vincristine 964Cetuximab 945Trastuzumab 945Prednisone 942Lenalidomide 937

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Sclerotherapy × Clear all
NCT06943703 2025-04-24

Bleomycin as an Effective and Curative Adjunct Therapy for Lymphangioma

National Children's Hospital, Vietnam

Completed
809 enrolled

Lymphangioma, Lymphatic Abnormalities

NCT02800980 2019-04-05

Management of Symptomatic Post-operative Lymphocele

Gdynia Oncology Center

Unknown
100 enrolled

Lymphocele

Data powered by HemOnc (CC BY 4.0) Colophon âš¡